Zhejiang Medicine Co., Ltd.
Zhejiang Medicine Co., Ltd., commonly referred to as ZMC, is a prominent player in the pharmaceutical industry, headquartered in China. Established in 1995, the company has made significant strides in the development and production of a diverse range of pharmaceutical products, including active pharmaceutical ingredients (APIs) and finished dosage forms. With a strong operational presence across various regions, ZMC is dedicated to innovation and quality, offering unique formulations that cater to both domestic and international markets. The company has achieved notable milestones, including certifications that underscore its commitment to excellence in manufacturing practices. Renowned for its robust portfolio, ZMC continues to solidify its market position through strategic partnerships and a focus on research and development, making it a key contributor to the global healthcare landscape.
DitchCarbon Score
How does Zhejiang Medicine Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Zhejiang Medicine Co., Ltd.'s score of 20 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Zhejiang Medicine Co., Ltd.'s reported carbon emissions
Zhejiang Medicine Co., Ltd., headquartered in CN, currently does not report any carbon emissions data, as there are no available figures for kg CO2e emissions. Additionally, the company has not established any specific reduction targets or initiatives related to climate commitments. Without emissions data or defined climate strategies, it is unclear how Zhejiang Medicine is addressing its environmental impact. The absence of reported figures suggests a potential area for improvement in transparency and accountability regarding carbon emissions and sustainability efforts.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Zhejiang Medicine Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
